Causes and Clinical Features of Raynaud's Phenomenon

Introduction to Raynaud's Phenomenon

Raynaud's phenomenon is primarily caused by excessive vasoconstriction of digital arteries in response to cold exposure or emotional stress, and can be classified as primary (idiopathic) or secondary to underlying conditions, with systemic sclerosis being the most common associated disease 1

Systemic sclerosis (scleroderma) is the most common association with secondary Raynaud's 1
Systemic lupus erythematosus is associated with secondary Raynaud's 1
Rheumatoid arthritis is associated with secondary Raynaud's 1
Thromboangiitis obliterans (Buerger's disease) is particularly associated with secondary Raynaud's in young tobacco smokers 1
Atherosclerosis with peripheral arterial disease is associated with secondary Raynaud's 1
Thromboembolic disease (both macroembolic and microembolic) is associated with secondary Raynaud's 1
Clotting system abnormalities (protein C, protein S, or antithrombin III deficiencies) are associated with secondary Raynaud's 1
Factor V Leiden or prothrombin mutations are associated with secondary Raynaud's 1
Hyperhomocysteinemia is associated with secondary Raynaud's 1
Presence of lupus anticoagulant or anticardiolipin antibody is associated with secondary Raynaud's 1
Chronic cold exposure is associated with secondary Raynaud's 1
Radiation-associated arteritis is associated with secondary Raynaud's 1
Vibration injury is associated with secondary Raynaud's 1
Ergot alkaloids can induce secondary Raynaud's 1
Bleomycin can induce secondary Raynaud's 1
Clonidine can induce secondary Raynaud's 1
Beta-blockers can induce secondary Raynaud's 1
Primary biliary cirrhosis is associated with secondary Raynaud's 1
Malignancies (paraneoplastic phenomenon) are associated with secondary Raynaud's 1

Secondary Raynaud's may involve the entire hand rather than just individual digits 2
Secondary Raynaud's has more severe manifestations with potential for digital ulcers, gangrene, or osteomyelitis 3

Severe, painful episodes are a red flag for secondary Raynaud's 1
Digital ulceration or tissue necrosis is a red flag for secondary Raynaud's 1
Associated systemic symptoms (e.g., joint pain, skin changes, dysphagia) are a red flag for secondary Raynaud's 1

Digital ulcers occur in 22.5% of patients with systemic sclerosis-associated Raynaud's 3
Gangrene occurs in 11% of patients with systemic sclerosis-associated Raynaud's 3
Osteomyelitis may develop in severe cases of secondary Raynaud's 3
In extreme cases, amputation might be required for patients with secondary Raynaud's 3

Weight loss, malaise, and fatigue may accompany connective tissue disease-related Raynaud's, according to the American Thoracic Society 4
Joint pains, musculoskeletal pain, weakness, fever, photosensitivity, pleuritis, dry eyes, and dry mouth suggest underlying connective tissue disease, as noted by the American College of Rheumatology 4
Fever is rare in primary Raynaud's; its presence suggests alternative diagnosis or underlying connective tissue disease, as reported by the American Journal of Respiratory and Critical Care Medicine 4

Mixed connective tissue disease/overlap syndromes are associated with secondary Raynaud's phenomenon, and the pathophysiological mechanisms may involve a "pulmonary Raynaud's phenomenon" (pulmonary vasospasm), with immunological mechanisms suggested by the presence of antinuclear antibodies, rheumatoid factor, immunoglobulin-G, and complement deposits in pulmonary vessel walls 5
HIV-related conditions are associated with secondary Raynaud's phenomenon, representing pulmonary arterial hypertension rather than typical Raynaud's 5

Lifestyle factors, including increased BMI, caffeine intake, sedentary lifestyle, and tobacco use, may contribute to Raynaud's symptoms, as noted by the Journal of the American Geriatrics Society 6

Certain medications, such as tricyclic antidepressants, SSRIs, lithium, and dopamine antagonists, have been reported to exacerbate symptoms, although this specific citation is from a different condition, it highlights the potential for various medications to impact Raynaud's-like conditions 6